Cargando…

Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program

SUMMARY: This study evaluated the 2-year persistence with teriparatide in the Netherlands. Analyses showed that the risk of non-persistence was 28% lower in patients who were followed according to an additional educational and motivational support program. INTRODUCTION: Until recently, teriparatide...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Maren, M.A., Wyers, C.E., Driessen, J.H.M., Visser, J.V., de Vries, F., van de Wijdeven, K., Gevers, S., Lems, W.F., Emmelot-Vonk, M.H., van den Bergh, J.P.W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717185/ https://www.ncbi.nlm.nih.gov/pubmed/31321446 http://dx.doi.org/10.1007/s00198-019-05052-0

Ejemplares similares

The risk of new fragility fractures in patients with chronic kidney disease and hip fracture—a population-based cohort study in the UK
por: de Bruin, I.J.A., et al.
Publicado: (2020)

Vertebral bone attenuation in Hounsfield Units and prevalent vertebral fractures are associated with the short-term risk of vertebral fractures in current and ex-smokers with and without COPD: a 3-year chest CT follow-up study
por: van Dort, M.J., et al.
Publicado: (2019)

Associations between bone attenuation and prevalent vertebral fractures on chest CT scans differ with vertebral fracture locations
por: Driessen, J.H.M., et al.
Publicado: (2021)

The influence of bone mineral density and cortical index on the complexity of fractures of the proximal humerus
por: den Teuling, J.W.A.M., et al.
Publicado: (2017)

Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures
por: Treurniet, Sanne, et al.
Publicado: (2023)

Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture
por: van der Velde, R. Y., et al.
Publicado: (2017)

Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey
por: Peeters, Joséphine Jeanne Maria, et al.
Publicado: (2021)

Evaluation of treatment outcome using the Patient Specific Functional Scale in knee osteoarthritis patients undergoing multidisciplinary rehabilitation
por: Moore, H.E., et al.
Publicado: (2020)

Fracture Patterns in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review of Recent Literature
por: Van Hulten, V., et al.
Publicado: (2021)

All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
por: de Bruin, I. J. A., et al.
Publicado: (2019)

Course and predictors of upper leg muscle strength over 48 months in subjects with knee osteoarthritis: Data from the osteoarthritis initiative
por: de Zwart, A.H., et al.
Publicado: (2020)

Teriparatide for osteoporosis: importance of the full course
por: Lindsay, R., et al.
Publicado: (2016)

The association between prevalent vertebral fractures and bone quality of the distal radius and distal tibia as measured with HR-pQCT in postmenopausal women with a recent non-vertebral fracture at the Fracture Liaison Service
por: Vranken, L., et al.
Publicado: (2019)

Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
por: Jakob, F, et al.
Publicado: (2012)

Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
por: Jakob, F, et al.
Publicado: (2012)

Physical Functioning in Patients with a Recent Fracture: The “Can Do, Do Do” Framework Applied to Explore Physical Capacity, Physical Activity and Fall Risk Factors
por: Schene, M. R., et al.
Publicado: (2023)

A first step towards a framework for interventions for individual working practice to prevent work-related musculoskeletal disorders: a scoping review
por: van de Wijdeven, Bert, et al.
Publicado: (2023)

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)
por: Fahrleitner-Pammer, A., et al.
Publicado: (2010)

Contextual determinants influencing the implementation of fall prevention in the community: a scoping review
por: van Scherpenseel, M. C., et al.
Publicado: (2023)

Amount and Distribution of Intracranial Calcification in Symptomatic and Asymptomatic Primary Familial Brain Calcification
por: Golüke, Nienke M.S., et al.
Publicado: (2023)

Prognostic value of screening instrument based on the Dutch national VMS guidelines for older patients in the emergency department
por: Snijders, B. M. G., et al.
Publicado: (2020)

Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study
por: Ljunggren, Östen, et al.
Publicado: (2013)

Determinants of pain and activity limitations in foot osteoarthritis: An exploratory cross-sectional study in the Amsterdam-foot cohort
por: Ryman, V.F.M., et al.
Publicado: (2021)

Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer
por: Chargi, N., et al.
Publicado: (2019)

Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007)

PINP as a biological response marker during teriparatide treatment for osteoporosis
por: Krege, J. H., et al.
Publicado: (2014)

The Phenotype of Patients with a Recent Fracture: A Literature Survey of the Fracture Liaison Service
por: Vranken, Lisanne, et al.
Publicado: (2017)

Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS)
por: Walsh, J. Bernard, et al.
Publicado: (2012)

Effect of Denosumab and Teriparatide on Fracture Nonunion
por: Boutin, Regine, et al.
Publicado: (2023)

Assessment of Individual Fracture Risk: FRAX and Beyond
por: van den Bergh, Joop P. W., et al.
Publicado: (2010)

Decreased Mortality and Subsequent Fracture Risk in Patients With a Major and Hip Fracture After the Introduction of a Fracture Liaison Service: A 3‐Year Follow‐Up Survey
por: Vranken, Lisanne, et al.
Publicado: (2022)

The epidemiology of fractures in Denmark in 2011
por: Driessen, J. H. M., et al.
Publicado: (2016)

High prevalence of vertebral fractures at initiation of androgen deprivation therapy for prostate cancer
por: van Oostwaard, Marsha M., et al.
Publicado: (2022)

Severe hypercalcemia due to teriparatide
por: Karatoprak, Cumali, et al.
Publicado: (2012)

Teriparatide – Indications beyond osteoporosis
por: Cheng, Marilyn Lee, et al.
Publicado: (2012)

Therapy of Osteoporosis in Men with Teriparatide
por: Cusano, Natalie E., et al.
Publicado: (2011)

Teriparatide in Fracture Non-Unions
por: Coppola, C., et al.
Publicado: (2014)

Chronic hypoparathyroidism and treatment with teriparatide
por: Marcucci, Gemma, et al.
Publicado: (2021)

Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
por: Vranken, L., et al.
Publicado: (2017)

Weight change during chemotherapy in breast cancer patients: a meta-analysis
por: van den Berg, M.M.G.A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h07fqvd75alhfoc4nd68v16554